Medical 3D Printing Market Growth set to be driven by Patient Specific 3D Printed Implants and Rising Adoption of POC in 3D printing : Global Analysis & Forecasts

The Medical device 3D printing market is poised to revolutionize the global healthcare industry. It is being increasingly used in medical and dental market for prototyping; producing anatomic models for surgical planning; making surgical guides; and manufacture of implants, instruments and prosthetics. Growing preference for medical device 3D printing over traditional machining methods owing to advantages such as less wastage of materials, cost effectiveness for smaller batches/more complex shapes and better clinical outcomes is driving the medical device 3D printing market growth. Moreover, the rising aging population, steady growth in Orthopaedics and dental procedures, and improving reimbursement scenario are other important factors driving the medical 3D printing market growth. In terms of opportunities, underpenetrated applications such as regenerative medicine and point of care 3D printing are likely to be the high growth areas of the medical 3D printing market in the upcoming years.

Global Medical 3D Printing market pegged at $1.5-2 billion (2020) and growing at a lucrative rate of 15-20% CAGR.

Medi-Tech Insights’ latest report on medical 3D printing market analyses it with respect to product, application, technology, end user, and region.

Based on our research & interviews with industry experts, it is evident that surgical planning & patient specific implants are the major applications today while US is largest geographic market with China emerging very quickly as a large medical 3D printing market.

“Orthopaedics and CMF surgeons are increasingly adopting surgical planning and associated tools made using 3D printing, as they understand the positive impact of patient specific solutions/products on clinical outcomes”   - CEO, Leading Medical 3D Printing Company 

Competitive Landscape Analysis : Medical 3D Printing Market

In terms of competitive landscape analysis, 3D Systems, Stratasys, Materialise Medical, EOS 3D, Arcam, SLM Solutions, and Concept Laser are some of the major players in the medical device 3D printing market. On the other hand, Orchestrate 3D, Tiertime 3D, T&R BioFab, Anatomics, LIMA, Biomodel, and PVA Med are some emerging players in medical device 3D printing market. This research report provides detailed analysis of key players with respect to business and financial overview, key growth strategies, and developments.

Investment Trends and Pricing Intelligence: Global Medical 3D Printing Market

Benefits aside, 3D printing’s high initial cost and lack of reimbursement have been restraining the medical device 3D printing market growth to some extent. Commercial printers usually range from $10,000 to $500,000. Further, there is cost associated with fixed annual fees for segmentation software, lab space, resource cost and so on. Drawn by the huge promise to disrupt healthcare, many VCs/Investors have backed companies in medical device 3D printing market. For example, Lightforce Orthodontics, which enables orthodontists to use 3D printing to make custom braces for patients, raised $14 million in Series B funding in September 2020. Similarly, Aspect Biosystems, a developer of microfluidic 3D bioprinting for human tissue-based therapeutics, raised $20 million in a Series A round in January 2020.

For More Detailed Insights and Customized Requirements, Contact Us @ https://meditechinsights.com/contact-us/

Comments

Post a Comment

Popular posts from this blog

Global HPV Testing and PAP Test Market is slated to grow at a lucrative CAGR of 12 to 15 % by 2027 – Growing Revolution for the Prevention of Cervical Cancer

Cervical cancer is a malignant tumor which starts in the cells of the cervix, the lowermost part of the uterus. Cervical cancer begins when the cells on its surface transforms into precancerous cells. If not destroyed, these abnormal cells may turn into harmful cancer cells and spread in the cervix and surrounding areas. Cervical cancer screening involves HPV and PAP tests , which can identify HPV infection or pre-cancerous lesions at an early stage and if correct treatment is offered at the right time then the cancer can be prevented. Impact of  Covid-19 on  the Global HPV Testing and PAP Test Market Covid-19 pandemic had impacted the healthcare market in many ways. During Covid pandemic, due to strict social-distancing norms in hospitals, there was a delay in many diagnostic examinations and procedures. The delay in the cancer screening services due to the lack of skilled healthcare staff and disruption in the supply chain of testing kits across the world had led to a severe impact o
Read more

Global Ambulatory Surgical Center (ASC) Software Market is Poised to Grow at a CAGR of 10% by 2027

Ambulatory Surgical Care is a medical care offered in the outpatient setting and does not need any hospital admission. Ambulatory Surgical Center or ASCs—are health care facilities focused on offering same-day surgical care, including diagnostic and preventive procedures. ASCs have transformed the outpatient experience by offering a convenient alternative to hospital-based outpatient procedures. Common procedures performed in ASCs are cataract surgery, gallbladder removal, tonsillectomy, endoscopy, colonoscopy, arthroscopic or orthopedic procedures, and cardiac procedures. Owing to their various cost benefits and convenience, the volume of procedures performed at ASCs is rising and ASC software is likely to play a major role in these settings by easing the day to day operations by preparing staff and patients for pre-op and post-op tasks. Rising Investments in Ambulatory Surgical Center  from Healthcare Companies Shows a Huge Growth Potential for Ambulatory Surgical Center Software Ma
Read more

Global Drug Discovery Software market valued at $2 billion in 2020, is projected to grow at a healthy CAGR of 14% to reach $3.5 billion by 2025

The global drug discovery software market (such as ligand-based design, structure-based design, LIMS, ELN) is driven by the increasing R&D spend and pipeline, expanding scope and scale, increasing stringency of testing and regulations, growing number and size of biotechs, need for increasing cost efficiencies and reducing time to market, and move towards web/cloud-based software. Global Drug Discovery Software Market – Niche but Fast-Growing Market The worldwide drug discovery software market is niche and growing rapidly, driven by the rising pressure on the pharma and biotech companies to cut costs in the research and preclinical stage of drug development, reduce timelines and improve transparency through deep learning software tools. “ Large players present in this segment are trying to consolidate the market by becoming a one stop shop. Moreover, companies are also considering to combine their solutions with bioinformatics and LIMS tools to have a competitive edge .” - Exe
Read more